Gross haematuria in the era of anticoagulant therapy – Implications on treatment and diagnostic approaches in a large emergency department patient population
Clinically significant gross haematuria is often associated with the intake of anticoagulant or antiplatelet medication and can unmask underlying malignant diseases. The intake of anticoagulation or antiplatelet therapy should not be a reason to postpone diagnostic and therapeutic measures.
Authors
- Markus Resch
- Simon Engelmann (ORCID: https://orcid.org/0000-0003-3810-3307)
- Maximilian Haas (ORCID: https://orcid.org/0000-0003-3132-0130)
- Roman Mayr (ORCID: https://orcid.org/0000-0003-1796-3260)
- Johannes Breyer (ORCID: https://orcid.org/0000-0003-0674-4150)
- Yushan Yang
- Johanna Seidl
- Maximilian Burger (ORCID: https://orcid.org/0009-0005-5013-9435)
Institutions
- University Hospital Augsburg (DE)
- University Hospital Regensburg (DE)
- St. Josef-Hospital (DE)
- Caritas-Krankenhaus St. Josef (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/bco2.70099
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00